elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Helicobacter pylori
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Helicobacter pylori
RIS
0.001
(Research Intensity Score)
Papers
117
Top papers
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions
2025 · 63 citations
Screening and eradication of Helicobacter pylori f or gastric cancer prevention: Taipei Global Consensus II
2025 · 47 citations
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
2024 · 69 citations
Metal–Organic‐Framework‐Based Hydrogen‐Release Platform for Multieffective Helicobacter Pylori Targeting Therapy and Intestinal Flora Protective Capabilities
2021 · 154 citations
A scoping review of worldwide guidelines for diagnosis and treatment of Helicobacter pylori infection
2025 · 22 citations
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
2020 · 201 citations
Reactive oxygen species and gastric carcinogenesis: The complex interaction between Helicobacter pylori and host
2023 · 39 citations
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)
2025 · 17 citations
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
2017 · 1607 citations
Newest papers
Long-term use of potassium-competitive acid blockers and proton pump inhibitors and the risk of metachronous gastric cancer after H. pylori eradication: a multicenter cohort study
2026 · 3 citations
Eco-Friendly Synthesis and Characterization of Calotropis gigantea-Derived Silver Nanoparticles for Combating Antibiotic-Resistant Helicobacter pylori and Gastric Cancer Cells
2026 · 2 citations
Efficacy and safety of bismuth quadruple therapy containing minocycline and berberine for initial eradication of Helicobacter pylori: A noninferiority, randomized controlled trial
2026 · 1 citations
Helicobacter pylori promote M1 macrophage polarization via JAK3-mediated activation of the SOCS3/IL2RA axis to suppress host immunity
2026
Efficacy and Safety of Tegoprazan Combined with High-Dose Amoxicillin Dual Therapy versus Bismuth-Containing Quadruple Therapy for <em>Helicobacter pylori</em> Eradication: A Prospective Cohort Study<div id="word-selection-translate-icon" class="bt-notranslate"><div id="word-selection-translate-icon" class="bt-notranslate" style="position: fixed; left: 346.467px; top: 21.6855px; z-index: 2147483647; pointer-events: auto;"><div style="width: 32px; height: 32px; background: rgb(0, 190, 202); border-radius: 50%; display: flex; align-items: center; justify-content: center; cursor: pointer; box-shadow: rgba(0, 0, 0, 0.15) 0px 2px 8px; transition: transform 0.2s, background-color 0.2s; pointer-events: all;"> </div></div></div>
2026
Comparison of Keverprazan-based versus esomeprazole-based dual therapy for initial treatment of Helicobacter pylori infection: a prospective, multicenter, randomized controlled trial
2026
Exploration of the Interaction Between Bismuth-Containing Quadruple Anti-H. pylori Therapy and the Gut Microbiota
2026
Clinical Spectrum, Endoscopic Findings, and Eradication Outcomes of Helicobacter pylori Infection in Eastern Libya
2026
Antibiotic Resistance Landscape and Genomic Characterization of Helicobacter pylori in Western Inner Mongolia, China
2026
Browse all papers →
Helicobacter pylori's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Helicobacter pylori's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link